These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30288116)
61. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Da Fonseca LG; Hashizume PH; de Oliveira IS; Izquierdo-Sanchez L; Saud LRDC; Xerfan MP; Alves VAF; de Mello ES; Herman P; Banales JM; Oliveira CP; Carrilho FJ Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884542 [TBL] [Abstract][Full Text] [Related]
62. Hepatitis B virus infection and the risk of cancer among the Chinese population. Tian T; Song C; Jiang L; Dai J; Lin Y; Xu X; Yu C; Ge Z; Ding Y; Wen Y; Liu B; Shao Y; Shi P; Zhu C; Liu Y; Jing S; Wang Z; Hu Z; Li J Int J Cancer; 2020 Dec; 147(11):3075-3084. PubMed ID: 32478856 [TBL] [Abstract][Full Text] [Related]
63. Intrahepatic cholangiocarcinoma: new insights in pathology. Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350 [TBL] [Abstract][Full Text] [Related]
64. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis. Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863 [TBL] [Abstract][Full Text] [Related]
65. Cooling methods of targeted temperature management and neurological recovery after out-of-hospital cardiac arrest: A nationwide multicenter multi-level analysis. Kim KH; Shin SD; Song KJ; Ro YS; Kim YJ; Hong KJ; Jeong J; Park JH; Kim TH; Kong SY Resuscitation; 2018 Apr; 125():56-65. PubMed ID: 29409768 [TBL] [Abstract][Full Text] [Related]
66. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585 [TBL] [Abstract][Full Text] [Related]
67. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Saha SK; Zhu AX; Fuchs CS; Brooks GA Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463 [TBL] [Abstract][Full Text] [Related]
68. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma. Tang Z; Yang Y; Wang X; Meng W; Li X BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476 [TBL] [Abstract][Full Text] [Related]
69. Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma. Liang Q; Liu H; Zhang T; Jiang Y; Xing H; Zhang H Mol Biosyst; 2016 Feb; 12(2):334-40. PubMed ID: 26646623 [TBL] [Abstract][Full Text] [Related]
71. Inpatient Palliative Care Is Less Utilized in Rare, Fatal Extrahepatic Cholangiocarcinoma: A Ten-Year National Perspective. Mojtahedi Z; Yoo JW; Callahan K; Bhandari N; Lou D; Ghodsi K; Shen JJ Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639305 [TBL] [Abstract][Full Text] [Related]
72. Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study. Lee BS; Cha BH; Park EC; Roh J Liver Int; 2015 Mar; 35(3):1048-53. PubMed ID: 24923595 [TBL] [Abstract][Full Text] [Related]
73. MiR-30a-5p promotes cholangiocarcinoma cell proliferation through targeting SOCS3. Zhang JW; Wang X; Li GC; Wang D; Han S; Zhang YD; Luo CH; Wang HW; Jiang WJ; Li CX; Li XC J Cancer; 2020; 11(12):3604-3614. PubMed ID: 32284757 [No Abstract] [Full Text] [Related]
74. BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways. Jiao CY; Feng QC; Li CX; Wang D; Han S; Zhang YD; Jiang WJ; Chang J; Wang X; Li XC Cell Death Dis; 2021 Jan; 12(1):63. PubMed ID: 33431813 [TBL] [Abstract][Full Text] [Related]
75. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120 [TBL] [Abstract][Full Text] [Related]
76. Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma. Zhou SL; Xin HY; Sun RQ; Zhou ZJ; Hu ZQ; Luo CB; Wang PC; Li J; Fan J; Zhou J JAMA Surg; 2022 Jan; 157(1):59-65. PubMed ID: 34730772 [TBL] [Abstract][Full Text] [Related]
77. Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up. Nishioka T; Kubo S; Tanaka S; Wakasa K; Takemura S; Kinoshita M; Hamano G; Kuwae Y; Shibata T; Suehiro S Liver Cancer; 2016 Apr; 5(2):107-20. PubMed ID: 27386429 [TBL] [Abstract][Full Text] [Related]
78. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience. Hrudka J; Prouzová Z; Mydlíková K; Jedličková K; Holešta M; Whitley A; Havlůj L Pathol Oncol Res; 2021; 27():1609756. PubMed ID: 34257615 [TBL] [Abstract][Full Text] [Related]
79. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis. Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070 [TBL] [Abstract][Full Text] [Related]
80. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study. Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]